Consumer Goods & Retailing
Asia-pacific Cough Syrup Market Forecast 2023-2032
Asia-pacific Cough Syrup Market Forecast 2023-2032
Asia-pacific Cough Syrup Market Forecast 2023-2032
KEY FINDINGS
The Asia-Pacific cough syrup market is set to project a CAGR of 4.01% during the forecast period, 2023-2032. Numerous nations in Asia-Pacific are experiencing aging populations, leading to an increased vulnerability among the elderly to respiratory diseases. This demographic shift has resulted in a growing demand for specialized cough syrups tailored to meet the specific requirements of this aging demographic.
MARKET INSIGHTS
South Korea, China, Vietnam, Australia & New Zealand, Indonesia, Japan, Thailand, India, and Rest of Asia-Pacific are analyzed for the Asia-Pacific cough syrup market growth evaluation. Respiratory illnesses like the common cold, flu, and cough-related conditions are becoming more common in South Korea. Recent health data indicates a rising prevalence of these respiratory disorders, affecting a significant portion of the population annually. Factors such as air pollution, seasonal variations, and lifestyle choices all contribute to the growing incidence of respiratory disorders, leading to an increased need for effective medications like cough syrups.
South Korea is currently undergoing a demographic transformation due to its aging population. A substantial portion of the population is aged 65 and above, and this demographic segment is expanding rapidly. Given that the elderly are more susceptible to respiratory infections, this demographic shift is driving up the demand for cough syrups, as this age group seeks reliable remedies for the common symptoms of coughs and colds.
Further, the increase in fatalities associated with cough syrup usage, along with the subsequent removal of five cough and fever syrup brands by the Indonesian Food and Drug Monitoring Agency in 2021, is expected to exert a substantial influence on Indonesia's cough syrup market.
COMPETITIVE INSIGHTS
Some of the key companies in the market are Novartis AG, Merck KGaA, Pfizer Inc, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation caters to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• The competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.